Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Net Income towards Common Stockholders: 2018-2020

Historic Net Income towards Common Stockholders for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $552.7 million.

  • Genmab A's Net Income towards Common Stockholders rose 362.62% to $169.09 in Q2 2021 from the same period last year, while for Jun 2021 it was $356.29, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $552.7 million for FY2020, which is 145.38% up from last year.
  • Latest data reveals that Genmab A reported Net Income towards Common Stockholders of $552.7 million as of FY2020, which was up 145.38% from $225.3 million recorded in FY2019.
  • Over the past 5 years, Genmab A's Net Income towards Common Stockholders peaked at $552.7 million during FY2020, and registered a low of $162.7 million during FY2018.
  • Its 3-year average for Net Income towards Common Stockholders is $313.6 million, with a median of $225.3 million in 2019.
  • Data for Genmab A's Net Income towards Common Stockholders shows a peak YoY soared of 145.38% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Genmab A's Net Income towards Common Stockholders stood at $162.7 million in 2018, then surged by 38.41% to $225.3 million in 2019, then surged by 145.38% to $552.7 million in 2020.